Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

STEM CELL BIOLOGY

USP4 regulates ribosome biogenesis and protein synthesis for hematopoietic stem cell regeneration and leukemia progression

Abstract

Enhanced ribosome biogenesis and protein synthesis are required for cell proliferation. During hematopoietic regeneration, hematopoietic stem cells (HSCs) proliferate rapidly to replenish the hematopoietic system. How HSCs respond and regulate ribosome biogenesis and protein synthesis during regeneration remains unclear. Here, we analyzed the expression of a series of ubiquitin-specific-proteases (USPs) during HSC regeneration. We found USP4 expression is significantly increased in proliferating HSCs. Further functional and mechanistic investigations revealed a crucial regulatory function of USP4 in HSC regeneration and leukemia progression by modulating ribosome biogenesis and protein synthesis. USP4 deubiquitinates and stabilizes PES1 to facilitate ribosome biogenesis and protein synthesis in proliferative HSCs and leukemic cells. Usp4 deletion significantly decreases protein synthesis, proliferation and reconstitution capacity of HSCs. Usp4 inhibition suppresses ribosome biogenesis and proliferation of leukemic cells, and prolongs the survival of AML (Acute myeloid leukemia) mice. These findings provide a new insight into the response mechanism of ribosome biogenesis and protein synthesis in HSCs, and their contribution to leukemia progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: USP4 is localized in nucleolus and upregulated during HSCs proliferation.
Fig. 2: Usp4 deletion impairs hematopoietic reconstitution capacity of HSCs.
Fig. 3: USP4 is required for HSC proliferation in response to regeneration.
Fig. 4: USP4 regulates ribosome biogenesis and protein synthesis in HSPCs.
Fig. 5: USP4 regulates HSC function by stabilizing PES1.
Fig. 6: USP4 inhibition suppresses myeloid leukemia progression.
Fig. 7: USP4 regulates ribosome biogenesis and protein synthesis in leukemia cells through PES1.

Similar content being viewed by others

Data availability

All data needed to evaluate the conclusions in the paper are present in the paper and/or Supplementary Materials. The sequencing datasets used in this study were derived from the NCBI Gene Expression Omnibus (GEO) database (GSE179415 and GSE164283).

References

  1. Mohrin M, Bourke E, Alexander D, Warr MR, Barry-Holson K, Le Beau MM, et al. Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell. 2010;7:174–85.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Wang Y, Schulte BA, LaRue AC, Ogawa M, Zhou D. Total body irradiation selectively induces murine hematopoietic stem cell senescence. Blood. 2006;107:358–66.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Yahata T, Takanashi T, Muguruma Y, Ibrahim AA, Matsuzawa H, Uno T, et al. Accumulation of oxidative DNA damage restricts the self-renewal capacity of human hematopoietic stem cells. Blood. 2011;118:2941–50.

    Article  PubMed  CAS  Google Scholar 

  4. Signer RA, Magee JA, Salic A, Morrison SJ. Haematopoietic stem cells require a highly regulated protein synthesis rate. Nature. 2014;509:49–54.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Cai X, Gao L, Teng L, Ge J, Oo ZM, Kumar AR, et al. Runx1 deficiency decreases ribosome biogenesis and confers stress resistance to hematopoietic stem and progenitor cells. Cell Stem Cell. 2015;17:165–77.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Lv K, Gong C, Antony C, Han X, Ren JG, Donaghy R, et al. HectD1 controls hematopoietic stem cell regeneration by coordinating ribosome assembly and protein synthesis. Cell Stem Cell. 2021;28:1275–90.e9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Magee JA, Signer RAJ. Developmental stage-specific changes in protein synthesis differentially sensitize hematopoietic stem cells and erythroid progenitors to impaired ribosome biogenesis. Stem Cell Rep. 2021;16:20–8.

    Article  CAS  Google Scholar 

  8. Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson DO, Wu H, et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature. 2006;441:475–82.

    Article  PubMed  CAS  Google Scholar 

  9. Kang J, Brajanovski N, Chan KT, Xuan J, Pearson RB, Sanij E. Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy. Signal Transduct Target Ther. 2021;6:323.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Narla A, Ebert BL. Ribosomopathies: human disorders of ribosome dysfunction. Blood. 2010;115:3196–205.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Sulima SO, Hofman IJF, De Keersmaecker K, Dinman JD. How ribosomes translate cancer. Cancer Discov. 2017;7:1069–87.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Growney JD, Shigematsu H, Li Z, Lee BH, Adelsperger J, Rowan R, et al. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood. 2005;106:494–504.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Fan YH, Yu Y, Mao RF, Tan XJ, Xu GF, Zhang H, et al. USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation. Cell Death Differ. 2011;18:1547–60.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Wang L, Zhao W, Zhang M, Wang P, Zhao K, Zhao X, et al. USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I. J Virol. 2013;87:4507–15.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Liu H, Zhang H, Wang X, Tian Q, Hu Z, Peng C, et al. The deubiquitylating enzyme USP4 cooperates with CtIP in DNA double-strand break end resection. Cell Rep. 2015;13:93–107.

    Article  PubMed  CAS  Google Scholar 

  16. Wijnhoven P, Konietzny R, Blackford AN, Travers J, Kessler BM, Nishi R, et al. USP4 auto-deubiquitylation promotes homologous recombination. Mol Cell. 2015;60:362–73.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Xiao N, Li H, Luo J, Wang R, Chen H, Chen J, et al. Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration. Biochem J. 2012;441:979–86.

    Article  PubMed  CAS  Google Scholar 

  18. Zhou F, Xie F, Jin K, Zhang Z, Clerici M, Gao R, et al. USP4 inhibits SMAD4 monoubiquitination and promotes activin and BMP signaling. EMBO J. 2017;36:1623–39.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Cao WH, Liu XP, Meng SL, Gao YW, Wang Y, Ma ZL, et al. USP4 promotes invasion of breast cancer cells via Relaxin/TGF-β1/Smad2/MMP-9 signal. Eur Rev Med Pharm Sci. 2016;20:1115–22.

    Google Scholar 

  20. Geng N, Li Y, Zhang W, Wang F, Wang X, Jin Z, et al. A PAK5–DNPEP–USP4 axis dictates breast cancer growth and metastasis. Int J Cancer. 2019;146:1139–51.

    Article  PubMed  Google Scholar 

  21. Guo W, Ma J, Pei T, Zhao T, Guo S, Yi X, et al. Up‐regulated deubiquitinase USP4 plays an oncogenic role in melanoma. J Cell Mol Med. 2018;22:2944–54.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Lai CY, Yeh DW, Lu CH, Liu YL, Chuang YC, Ruan JW, et al. Epigenetic silencing of ubiquitin specific protease 4 by Snail1 contributes to macrophage-dependent inflammation and therapeutic resistance in lung cancer. Cancers. 2020;12:148.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Liang Y, Song X, Li Y, Ma T, Su P, Guo R, et al. Targeting the circBMPR2/miR-553/USP4 axis as a potent therapeutic approach for breast cancer. Mol Ther Nucleic Acids. 2019;17:347–61.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Qiu C, Liu Y, Mei Y, Zou M, Zhao Z, Ye M, et al. Ubiquitin-specific protease 4 promotes metastasis of hepatocellular carcinoma by increasing TGF-β signaling-induced epithelial-mesenchymal transition. Aging. 2018;10:2783–99.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Wang Y, Zhou L, Lu J, Jiang B, Liu C, Guo J. USP4 function and multifaceted roles in cancer: a possible and potential therapeutic target. Cancer Cell Int. 2020;20:298.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Xing C, Lu XX, Guo PD, Shen T, Zhang S, He XS, et al. Ubiquitin-specific protease 4-mediated deubiquitination and stabilization of PRL-3 is required for potentiating colorectal oncogenesis. Cancer Res. 2016;76:83–95.

    Article  PubMed  CAS  Google Scholar 

  27. Deng L, Chen L, Zhao L, Xu Y, Peng X, Wang X, et al. Ubiquitination of Rheb governs growth factor-induced mTORC1 activation. Cell Res. 2019;29:136–50.

    Article  PubMed  CAS  Google Scholar 

  28. Joazeiro CAP. Mechanisms and functions of ribosome-associated protein quality control. Nat Rev Mol Cell Biol. 2019;20:368–83.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Dougherty SE, Maduka AO, Inada T, Silva GM. Expanding role of ubiquitin in translational control. Int J Mol Sci. 2020;21:1151.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Tsang CK, Bertram PG, Ai W, Drenan R, Zheng XF. Chromatin-mediated regulation of nucleolar structure and RNA Pol I localization by TOR. EMBO J. 2003;22:6045–56.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Yang K, Wang M, Zhao Y, Sun X, Yang Y, Li X, et al. A redox mechanism underlying nucleolar stress sensing by nucleophosmin. Nat Commun. 2016;7:13599.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Zillner K, Filarsky M, Rachow K, Weinberger M, Längst G, Németh A, et al. Large-scale organization of ribosomal DNA chromatin is regulated by Tip5. Nucleic Acids Res. 2013;41:5251–62.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Komorowska K, Doyle A, Wahlestedt M, Subramaniam A, Debnath S, Chen J, et al. Hepatic leukemia factor maintains quiescence of hematopoietic stem cells and protects the stem cell pool during regeneration. Cell Rep. 2017;21:3514–23.

    Article  PubMed  CAS  Google Scholar 

  34. Morrison SJ, Wright DE, Weissman IL. Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. Proc Natl Acad Sci. 1997;94:1908–13.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  35. Rathinam C, Matesic LE, Flavell RA. The E3 ligase Itch is a negative regulator of the homeostasis and function of hematopoietic stem cells. Nat Immunol. 2011;12:399–407.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Hölzel M, Grimm T, Rohrmoser M, Malamoussi A, Harasim T, Gruber-Eber A, et al. The BRCT domain of mammalian Pes1 is crucial for nucleolar localization and rRNA processing. Nucleic Acids Res. 2007;35:789–800.

    Article  PubMed  Google Scholar 

  37. Hölzel M, Rohrmoser M, Schlee M, Grimm T, Harasim T, Malamoussi A, et al. Mammalian WDR12 is a novel member of the Pes1-Bop1 complex and is required for ribosome biogenesis and cell proliferation. J Cell Biol. 2005;170:367–78.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Lapik YR, Fernandes CJ, Lau LF, Pestov DG. Physical and functional interaction between pes1 and bop1 in mammalian ribosome biogenesis. Mol Cell. 2004;15:17–29.

    Article  PubMed  CAS  Google Scholar 

  39. Liu L, Zhao M, Jin X, Ney G, Yang KB, Peng F, et al. Adaptive endoplasmic reticulum stress signalling via IRE1α-XBP1 preserves self-renewal of haematopoietic and pre-leukaemic stem cells. Nat Cell Biol. 2019;21:328–37.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Yi W, Zhang Y, Liu B, Zhou Y, Liao D, Qiao X, et al. Protein S-nitrosylation regulates proteostasis and viability of hematopoietic stem cell during regeneration. Cell Rep. 2021;34:108922.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  41. Hidalgo San Jose L, Sunshine MJ, Dillingham CH, Chua BA, Kruta M, Hong Y, et al. Modest declines in proteome quality impair hematopoietic stem cell self-renewal. Cell Rep. 2020;30:69–80.e6.

    Article  PubMed  CAS  Google Scholar 

  42. Sigurdsson V, Takei H, Soboleva S, Radulovic V, Galeev R, Siva K, et al. Bile acids protect expanding hematopoietic stem cells from unfolded protein stress in fetal liver. Cell Stem Cell. 2016;18:522–32.

    Article  PubMed  CAS  Google Scholar 

  43. Shenoy N, Kessel R, Bhagat TD, Bhattacharyya S, Yu Y, McMahon C, et al. Alterations in the ribosomal machinery in cancer and hematologic disorders. J Hematol Oncol. 2012;5:32.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  44. Choesmel V, Fribourg S, Aguissa-Touré AH, Pinaud N, Legrand P, Gazda HT, et al. Mutation of ribosomal protein RPS24 in Diamond-Blackfan anemia results in a ribosome biogenesis disorder. Hum Mol Genet. 2008;17:1253–63.

    Article  PubMed  CAS  Google Scholar 

  45. Flygare J, Aspesi A, Bailey JC, Miyake K, Caffrey JM, Karlsson S, et al. Human RPS19, the gene mutated in Diamond-Blackfan anemia, encodes a ribosomal protein required for the maturation of 40S ribosomal subunits. Blood. 2007;109:980–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  46. Ebert BL, Pretz J, Bosco J, Chang CY, Tamayo P, Galili N, et al. Identification of RPS14 as a 5q-syndrome gene by RNA interference screen. Nature. 2008;451:335–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  47. Scharenberg C, Giai V, Pellagatti A, Saft L, Dimitriou M, et al. Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations. Haematologica. 2017;102:498–508.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  48. Li Z, Hao Q, Luo J, Xiong J, Zhang S, Wang T, et al. USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2. Oncogene. 2016;35:2902–12.

    Article  PubMed  CAS  Google Scholar 

  49. Zhang X, Berger FG, Yang J, Lu X. USP4 inhibits p53 through deubiquitinating and stabilizing ARF-BP1. EMBO J. 2011;30:2177–89.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China [82030039, 92049304 and 82230047], the Guangdong Basic and Applied Basic Research Foundation [2023A1515010927], the National Key Research and Development Program of China [2022YFA1103503, 2021YFA1100103 and 2020YFA0112404], the Program for Guangdong Introducing Innovative and Entrepreneurial Teams [2017ZT07S347], the innovation team project of universities in Guangdong province [2023KCXTD004].

Author information

Authors and Affiliations

Authors

Contributions

BL and ZYJ designed the study. XLZ, BL, YYZ, HPL, ZKW and YTF performed experiments and analyzed data. BL, XLZ and ZYJ wrote the paper. QDG, XC and QYS provided additional expertise. BL and ZYJ supervised the study.

Corresponding authors

Correspondence to Bo Liu or Zhenyu Ju.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, B., Zhang, X., Zhou, Y. et al. USP4 regulates ribosome biogenesis and protein synthesis for hematopoietic stem cell regeneration and leukemia progression. Leukemia 38, 2466–2478 (2024). https://doi.org/10.1038/s41375-024-02338-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41375-024-02338-z

This article is cited by

Search

Quick links